Fig. 6From: Development of an Interpretable Deep Learning Model for Pathological Tumor Response Assessment After Neoadjuvant TherapyDemonstrative potential clinical application of the deep learning framework, enabling automated viable residual tumor percentage estimation and spatial mapping to augment pathological response assessmentBack to article page